---
title: "SITC Immunotherapy Guidelines - Reviews, Revenue and Downloads in United States | Apple App Store"
description: "The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or "
---

# SITC Immunotherapy Guidelines — United States

![SITC Immunotherapy Guidelines App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple211/v4/92/2d/77/922d7733-09bd-a1e5-316f-110488cac5b0/AppIcon-1x_U007emarketing-0-7-0-85-220-0.png/434x0w.png)

**Developer:** [SOCIETY FOR IMMUNOTHERAPY OF CANCER](https://apptail.io/developer/society-for-immunotherapy-of-cancer-Xnkd)
**Category:** Medical
**Rating:** 4.8/5 (78 ratings)
**Price:** Free
**Bundle ID:** org.sitcancer.guidelines
**Store:** Apple App Store
**Country:** United States
**Version:** 1.7 (released 2024-03-19)
**Original Release:** 2021-08-30
**Languages:** English, German

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/us/app/app/id1555408470)
**AppTail Page:** [https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/united-states](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/united-states)

## SITC Immunotherapy Guidelines Description
The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG App features evidence- and expert consensus based-recommendations on all aspects of immunotherapy treatment as well as interactive tools and companion educational resources. From biomarkers and therapy selection to quality of life and management of immune-related adverse events, busy clinicians will find the SITC CPG App as the go-to resource on when and how to use immunotherapy to help improve outcomes for patients with cancer. 

Key App Features

*Clean and simple navigation with a modern interface 
*Interactive tools and tables at your fingertips 
*Advanced search functionality for fast access to the content clinicians need  
*Bookmarking and annotation capabilities throughout for future fast-reference 
*Timely updates when new practice-changing data or approvals become available
*Companion educational offerings to enhance understanding of guideline recommendations
*Free download with open-access content

About SITC’s Guidelines 

SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine&#039;s 2011 &quot;Standards for Developing Trustworthy Clinical Practice Guidelines&quot; to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.


About SITC

SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org 

sitcancer.org/CPG-app
On social - #SITCGuidelines

## SITC Immunotherapy Guidelines Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource115/v4/14/a3/70/14a37021-0e4a-1da3-680f-c90e6db15046/8ef35f64-e8be-48a2-babd-d0cedc55a9cf_Simulator_Screen_Shot_-_iPhone_12_Pro_Max_-_2021-08-25_at_18.54.15.png/1284x2778.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource125/v4/41/ab/c0/41abc0b4-15c7-48c5-d300-a2437c40e1c7/e990d180-250e-489c-b060-94066d774185_3.png/1284x2778.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource115/v4/83/95/41/839541a8-36ee-8151-177e-8d7fc8d916a7/2df786d9-d34c-4df3-b202-8d4ac96b9694_4.png/1284x2778.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource125/v4/85/22/d5/8522d5b0-fa42-4819-25bc-c507b10be335/b78c1268-b146-42ed-8c3b-1602f35da6e4_5.png/1284x2778.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource115/v4/60/ba/6c/60ba6c25-f105-1bd9-35ad-1b2847ec9b22/d1b7c186-e355-4642-a156-6c5746731f51_6.png/1284x2778.png)
- [Screenshot 6](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource125/v4/af/7a/c1/af7ac10e-c75e-d490-06e8-5ce06ed4a77e/6580dd78-2dca-4eb7-80ea-112bf6918918_7.png/1284x2778.png)
- [Screenshot 7](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource115/v4/db/9a/9e/db9a9e1c-7757-5c5e-bbf4-71ecf28085a5/50f38cf7-d7b1-489b-a0b1-9cd6cefdab2c_8.png/1284x2778.png)
- [Screenshot 8](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource125/v4/52/b2/e4/52b2e494-a952-eb94-8797-54330925335b/10857804-fda9-43ff-8a5f-90708f27bcaf_9.png/1284x2778.png)

## SITC Immunotherapy Guidelines Rating Breakdown in United States
- 5 stars: 71 (91%)
- 4 stars: 4 (5%)
- 3 stars: 0 (0%)
- 2 stars: 1 (1%)
- 1 stars: 2 (3%)

## SITC Immunotherapy Guidelines Reviews in United States

### ***** "Nice app"
Nice information!!!
-- .BB@, 2022-01-06

[View all SITC Immunotherapy Guidelines reviews and detailed analytics on AppTail](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=reviews)




## Apps Similar to SITC Immunotherapy Guidelines
- [HemeOncBuddy](https://apptail.io/app/hemeoncbuddy-torb/united-states)
- [ASTCT Practice Guidelines](https://apptail.io/app/astct-practice-guidelines-htEb/united-states)
- [ESMO Interactive Guidelines](https://apptail.io/app/esmo-interactive-guidelines-OSRb/united-states)
- [Manual of Clinical Oncology](https://apptail.io/app/manual-of-clinical-oncology-PSRb/united-states)
- [Immuno-Oncology](https://apptail.io/app/immuno-oncology-npAc/united-states)
- [Physicians Cancer Chemotherapy](https://apptail.io/app/physicians-cancer-chemotherapy-jcDc/united-states)
- [ASCO Guidelines](https://apptail.io/app/asco-guidelines-mcDc/united-states)
- [ASH Pocket Guides](https://apptail.io/app/ash-pocket-guides-piZc/united-states)
- [Hem/Onc @Point of Care](https://apptail.io/app/hemonc-at-point-of-care-oZZc/united-states)
- [NCCN Patient Guides for Cancer](https://apptail.io/app/nccn-patient-guides-for-cancer-xvAd/united-states)

## SITC Immunotherapy Guidelines Available In
- [United States](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/united-states)
- [India](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/india)
- [Germany](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/germany)
- [United Kingdom](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/united-kingdom)
- [Italy](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/italy)
- [South Korea](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/south-korea)
- [China](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/china)
- [Australia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/australia)
- [Norway](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/norway)
- [Belgium](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/belgium)
- [Portugal](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/portugal)
- [Romania](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/romania)
- [Russia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/russia)
- [Saudi Arabia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/saudi-arabia)
- [Taiwan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/taiwan)
- [Brunei](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/brunei)
- [Switzerland](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/switzerland)
- [Vietnam](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/vietnam)
- [Indonesia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/indonesia)
- [Ireland](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/ireland)
- [Denmark](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/denmark)
- [Türkiye](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/turkey)
- [Greece](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/greece)
- [Peru](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/peru)
- [Canada](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/canada)
- [France](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/france)
- [Poland](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/poland)
- [Finland](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/finland)
- [Sweden](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/sweden)
- [Singapore](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/singapore)
- [Thailand](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/thailand)
- [Ukraine](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/ukraine)
- [Uzbekistan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/uzbekistan)
- [United Arab Emirates](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/united-arab-emirates)
- [South Africa](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/south-africa)
- [Argentina](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/argentina)
- [Austria](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/austria)
- [Azerbaijan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/azerbaijan)
- [Brazil](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/brazil)
- [Belarus](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/belarus)
- [Chile](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/chile)
- [Colombia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/colombia)
- [Czechia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/czechia)
- [Dominican Republic](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/dominican-republic)
- [Algeria](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/algeria)
- [Ecuador](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/ecuador)
- [Egypt](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/egypt)
- [Spain](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/spain)
- [Hong Kong SAR China](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/hong-kong)
- [Hungary](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/hungary)
- [Israel](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/israel)
- [Japan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/japan)
- [Kuwait](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/kuwait)
- [Kazakhstan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/kazakhstan)
- [Lebanon](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/lebanon)
- [Mexico](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/mexico)
- [Malaysia](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/malaysia)
- [Nigeria](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/nigeria)
- [Netherlands](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/netherlands)
- [New Zealand](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/new-zealand)
- [Philippines](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/philippines)
- [Pakistan](https://apptail.io/app/sitc-immunotherapy-guidelines-LSRb/pakistan)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*
